Curaleaf Holdings (CURLF) Assets Average (2020 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Assets Average of $3.0 billion for Q4 2024, down 4.72% year-on-year from $3.2 billion in Q1 2024, and down 2.16% on a QoQ basis from $3.1 billion in Q3 2024.
Curaleaf Holdings (CURLF) Assets Average (2020 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Assets Average for 5 consecutive years, with $3.0 billion the latest figure, recorded in Q4 2024.
- Quarterly Assets Average fell 4.72% year-over-year to $3.0 billion in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.0 billion (down 4.72% YoY) and the FY2025 annual result came in at $2.9 billion, down 4.16% from the prior year.
- Assets Average retreated to $3.0 billion in Q4 2024 per CURLF's latest filing, from $3.1 billion in the prior quarter.
- Over the last five years, Assets Average for CURLF reached as high as $3.3 billion in Q3 2023 and fell as low as $737.0 million in Q3 2022.
- A 5-year average of $2.4 billion and a median of $2.4 billion in 2020 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average plunged 76.71% — and 2023, when it soared 342.99%.
- Year by year, Assets Average stood at $2.4 billion in 2020, then dropped by 17.2% to $2.0 billion in 2021, then advanced by 6.13% to $2.1 billion in 2022, then jumped by 52.3% to $3.2 billion in 2023, then declined by 4.72% to $3.0 billion in 2024.
- According to Business Quant data, Assets Average over the past three periods registered $3.0 billion, $3.1 billion, and $3.2 billion for Q4 2024, Q3 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.01 Bn |
| Sep 30, 2024 | 3.08 Bn |
| Dec 31, 2023 | 3.16 Bn |
| Sep 30, 2023 | 3.26 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 2.08 Bn |
| Dec 31, 2022 | 2.08 Bn |
| Sep 30, 2022 | 737.03 Mn |
| Jun 30, 2022 | 2.14 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 1.96 Bn |
| Sep 30, 2021 | 3.16 Bn |
| Jun 30, 2021 | 2.92 Bn |
| Mar 31, 2021 | 2.52 Bn |
| Dec 31, 2020 | 2.36 Bn |